CurrentBody Acquires Tria Beauty, Leaders in At-Home Laser Hair Removal
CurrentBody has successfully acquired Tria Beauty. In 2003, the inventors of LightSheer™, a leading in-clinic laser hair removal technology, aimed to revolutionize at-home hair removal by creating a handheld laser…
Oscar Health Expands to New Markets in 2025 to Reach More Americans
Oscar Health, Inc. (NYSE: OSCR), a healthcare technology leader, announced today that it will expand its offerings in the ACA marketplace in 2025. This move aims to provide more individuals,…
MedTech Innovator Reveals 2024 Grand Prize and Award Winners at The MedTech Conference
MedTech Innovator (MTI), the leading accelerator for medical technology companies, has announced that Samay is the 2024 Grand Prize Winner, receiving $350,000 in non-dilutive funding. Based in Mountain View, California,…
Augurex Partners with ARUP Laboratories to Launch 14-3-3η Test for Rheumatoid Arthritis
Augurex Life Sciences Corp., a leader in autoimmune biomarker diagnostics, has announced that ARUP Laboratories, a prominent national reference lab in the U.S., has launched the 14-3-3η test as part…
CareDx Highlights HLA Typing Innovations at ASHI Annual Meeting
CareDx, Inc. (Nasdaq: CDNA), known as The Transplant Company™, announced today new data and product enhancements to be presented at the 50th annual meeting of the American Society for Histocompatibility…
BeiGene Gets CHMP Nod for TEVIMBRA® in Advanced Gastric and Esophageal Cancers
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has…
Endospan Completes Enrollment for NEXUS® Aortic Arch Stent Graft TRIOMPHE IDE Study
Endospan, a leader in endovascular solutions for the Aortic Arch, has announced the completion of enrollment for the primary arm of its TRIOMPHE Investigational Device Exemption (IDE) clinical study, which…
Bruker Unveils $100 High-Accuracy Plasma Proteome for Glycoproteomics and Metaproteomics
At the 23rd Human Proteome Organization World Congress, Bruker Corporation (Nasdaq: BRKR) announced significant advancements in deep, unbiased, and high-sensitivity 4D-Proteomics. These developments enable robust, high-fidelity, large-scale studies while minimizing…
NUCLIDIUM Begins Phase 1 Study of 61Cu Radiotracer in PSMA-Positive Prostate Cancer
NUCLIDIUM has announced the successful imaging of its first patient in a Phase 1 clinical trial for its radiotracer candidate, aimed at providing a safe and accurate diagnostic tool for…
ASDS 2024: Phase III READY-4 Data Show Long-Term Safety and Efficacy of Galderma’s Relfydess™
Galderma has announced new Phase III data from the READY-4 clinical trial, showcasing the long-term safety and efficacy of RelabotulinumtoxinA (Relfydess™) for treating frown lines and crow’s feet after repeated…
Blue Lake and CyanVac Present Intranasal Vaccines at ISV Congress
Blue Lake Biotechnology, Inc., a clinical-stage company focused on intranasal vaccines using parainfluenza virus 5 (PIV5) vectors, and its affiliate CyanVac LLC, announced the presentation of positive interim pediatric clinical…
Seaport Therapeutics Secures $225 Million in Oversubscribed Series B Funding
Seaport Therapeutics, a clinical-stage biopharmaceutical company focused on developing innovative neuropsychiatric medicines, has successfully closed an oversubscribed $225 million Series B financing round. The round was led by General Atlantic,…